Paula J Busse MD
Assistant Professor, Medicine, Icahn School of Medicine
Join to view full profile
5 E 98th StNew York, NY 10029
Phone+1 212-241-0764
Fax+1 212-534-0971
Dr. Busse is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Allergy and Immunology, 1999 - 2001- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1996 - 1999
University of Rochester School of Medicine and DentistryClass of 1996
Certifications & Licensure
NY State Medical License 1997 - 2028
American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- A Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema Participants Start of enrollment: 2014 May 14
- Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and Adults
- Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents Start of enrollment: 2022 May 04
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Sebetralstat for breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis in KONFIDENT-S.Tamar Kinaciyan, Emel Aygören-Pürsün, Inmaculada Martinez-Saguer, Daniel F Soteres, Daisuke Honda
The Journal of Allergy and Clinical Immunology. Global. 2026-09-01 - Lanadelumab Use for Hereditary Angioedema Long-Term Prophylaxis Over the Last 7 Years: A Narrative Review of Clinical and Real-World Data.Paula Busse, Andrea Zanichelli, Jonathan A Bernstein, John Anderson, Stephen Betschel
Clinical Reviews in Allergy & Immunology. 2026-08-08 - Impact of Cognitive Impairment and Depression on Asthma in Older Patients.Paula J Busse, E Sherwood Brown, Juan Wisnivesky, Alex Federman, William W Busse
The Journal of Allergy and Clinical Immunology. in Practice. 2026-07-03
Journal Articles
- Effect of Lanadelumab Compared with Placebo on Prevention of Hereditary Angioedema AttacksJonathan A Bernstein, Lawrence B Schwartz, Andrew M Smith, H James Wedner, Daniel Soteres, Timothy Craig, Douglas T Johnston, Aleena Banerji, Paula J Busse, William R ..., JAMA
Press Mentions
KalVista Pharmaceuticals Shares Latest Sebetralstat Findings at the American Academy of Allergy, Asthma & Immunology 2025 Annual MeetingMarch 3rd, 2025- Interim Phase 4 Data Support TAKHZYRO® (Lanadelumab) as an Effective Treatment to Reduce Attacks in Hereditary Angioedema PatientsFebruary 28th, 2022
- Children’s National Hospital Becomes Part of the National CAUSE Clinical Research Network Under a $3 Million GrantApril 26th, 2021
Grant Support
- Childhood Asthma in Urban SettingsICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2021–2028
- Contribution Of Tnf-Alpha To Mucus Cell Production In AsthmaNational Institute Of Allergy And Infectious Diseases2010
- C1 Esterase Inhibitor As Treatment And Prevention In Hereditary AngioedemaNational Center For Research Resources2009
- Contribution Of Tnf-Alpha To Mucus Cell Production In AsthmaNational Institute Of Allergy And Infectious Diseases2006–2009
- Change TrialNational Center For Research Resources2008
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
